It's not all black and white

Article

In some cases, it can be difficult for ophthalmologists to determine precisely what is affecting their patient. It is essential that a correct diagnosis is established as a misdiagnosis could have serious consequences for the patient; allowing the real problem to progress undetected. Here, Arashvand and Geh talk us through a case of orbital injury mimicking traumatic Brown's Syndrome.

The case

Muscle entrapment after orbital fracture usually involves the inferior rectus, while solitary inferior oblique entrapment is uncommon. In this case, solitary inferior oblique entrapment clinically mimics Brown's syndrome.

A patient with traumatic Brown's syndrome is more likely to complain of pain in the region of the trochlea, while the elevation deficiency produced by a blow-out fracture is usually more marked in abduction rather than adduction.2

How do we treat it?

There is no consensus on the optimal treatment for blowout fractures. Some authors recommend early surgical therapy while others advocate surgery only when conservative therapy has been ineffective. Diplopia persists in a significant number of patients following surgical treatment of a blowout fracture of the orbital floor, even when surgery is performed within 15 days after the traumatic incident.3 Our patient was managed conservatively and, after eight weeks, his diplopia was resolved with full recovery of ocular motility (Figure 3).

The case clearly highlights how inferior oblique muscle entrapment in an orbital floor fracture can mimic Brown's syndrome. These restrictive conditions are very similar clinically; therefore, attention to the nature of injury and imaging study are crucial to differentiate these two circumstances.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.